Some pediatric patients with low-risk acute myeloid leukemia (AML) can receive 4 cycles of chemotherapy, rather than 5, without affecting outcomes, according to research presented at the ASH Annual ...

The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...

The American Society of Hematology/ASH 2025 meeting included AML results from AAML1831, MyeChild01, BIG-1, and PALG-AML1/2016 studies.

Investigators evaluated outcomes for patients with pediatric AML with and without etoposide during first-line induction treatment.

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148 Included are 268 patients (age ≤ 18 years) with AML in second complete remission (n = 142), relapse (n = 90), or ...

Imagine conquering childhood cancer, only to find out that years down the road your heart may fail. Unfortunately, many children who have battled cancer face this reality. While often lifesaving, the ...

The chemotherapy treatments necessary to treat Acute Myeloid Leukemia (AML) in children can be grueling on the body, and can cause health-related complications during therapy, as well as long down the ...

Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation Purpose: To evaluate the ...

When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...

What is Acute Myeloid Leukemia? Acute myeloid leukemia is a severe form of cancer that originates in the bone marrow, where new blood cells are generated. According to the American Cancer Society, AML ...